Used in research for treating genetic disorders caused by nonsense mutations, particularly in diseases like Duchenne muscular dystrophy and cystic fibrosis. It promotes read-through of premature stop codons during translation, allowing production of full-length, functional proteins. Investigated for potential therapeutic use in clinical trials, especially where faulty protein synthesis is a key factor.